Antony A Riley insider trades

Open-market stock purchases and sales by Antony A Riley, CHIEF FINANCIAL OFFICER at Forte Biosciences, Inc, from SEC Form 4 filings since Mar 8, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +192%.

Recent trades

DateStockTradeValue
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$1.7M
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)—
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)—
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)—
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)—
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$13.1K
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$129K
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$242K
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$2.4M
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$2.7M
Aug 27, 2026FBRX Forte Biosciences, IncSold (not open market)$377K
Jul 1, 2026FBRX Forte Biosciences, IncSold (not open market)$2.9K
Jul 1, 2026FBRX Forte Biosciences, IncBought (not open market)—
Jun 16, 2026FBRX Forte Biosciences, IncBought (not open market)—
Apr 1, 2026FBRX Forte Biosciences, IncSold (not open market)$3.3K
Apr 1, 2026FBRX Forte Biosciences, IncBought (not open market)—
Jan 12, 2026FBRX Forte Biosciences, IncBought (not open market)—
Jan 12, 2026FBRX Forte Biosciences, IncBought (not open market)—
Jan 1, 2026FBRX Forte Biosciences, IncSold (not open market)$4.2K
Jan 1, 2026FBRX Forte Biosciences, IncBought (not open market)—
Dec 30, 2025FBRX Forte Biosciences, IncBought$255K

Companies traded

  • FBRX Forte Biosciences, Inc: 4 buys, 2 sales, last Aug 27, 2026
  • KRYS Krystal Biotech, Inc: 1 buy, last Nov 19, 2019

Get free alerts when Antony A Riley files a new trade →